NCT05745961View on ClinicalTrials.gov

Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

RecruitingOBSERVATIONAL

Enrollment

6

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

April 30, 2025

Conditions

Pulmonary Arterial HypertensionHealthy

Interventions

RADIATION

TSPO PET scan (11C-PBR28)

PET scan

Trial Locations (1)

NW3 2LE

RECRUITING

Imperial Clinical Research Facility, London

All Listed Sponsors

lead

Imperial College London

OTHER